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Crystal Structures of Two H-2Db/Glycopeptide
Complexes Suggest a Molecular Basis
for CTL Cross-Reactivity
circulating T lymphocytes. In recent years, there has
been increasing evidence to show that glycopeptides
can also be presented by MHC molecules in the same
way. Three examples of glycosylated antigens pre-
sented naturally by MHC class II have been reported to
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Summary carrying O-GlcNAc residues could enter the class I pre-
sentation pathway. We have shown that O-GlcNAc sub-
Two synthetic O-GlcNAc-bearing peptides that elicit stituted peptides can be efficiently translocated across
the ER membrane by the transporter associated withH-2Db-restricted glycopeptide-specific cytotoxic T cells
antigen processing (TAP) (Haurum, 1996) and that syn-(CTL) have been shown to display nonreciprocal pat-
thetic glycopeptides carrying single O-GlcNAc residuesterns of cross-reactivity. Here, we present the crystal
can bind to the murine class I molecule H-2Db and arestructures of the H-2Db glycopeptide complexes to
immunogenic (Haurum et al., 1994, 1995), giving rise to2.85 AÊ resolution or better. In both cases, the glycan
glycan-specific CTL. Two O-GlcNAc substituted pep-is solvent exposed and available for direct recognition
tides were used, both being analogs of the Sendai virusby the T cell receptor (TCR). We have modeled the
nucleoprotein residues 324±332 (FAPGNYPAL). This pep-complex formed between the MHC-glycopeptide com-
tide binds to H-2Db using the side-chains asparagine atplexes and their respective TCRs, showing that a sin-
position 5 and leucine at position 9 as anchor residuesgle saccharide residue can be accommodated in the
(Haurum et al., 1994). The glycopeptide analogs, FAPS(O-standard TCR-MHC geometry. The models also reveal
GlcNAc)NYPAL (designated K3G) and FAPGS(O-GlcNA-a possible molecular basis for the observed cross-
c)YPAL (designated K2G) thus carry the substitutionsreactivity patterns of the CTL clones, which appear to
on positions 4 and 5, respectively. In the case of K2G,be influenced by the length of the CDR3 loop and the
this is a modification of the P5 anchor residue.nature of the immunizing ligand.
We have raised H-2Db CTL against both of these gly-
copeptides in C57Bl/6 mice. Surprisingly, immunizationIntroduction
with K2G readily elicited an H-2Db-restricted CTL re-
sponse despite the fact that it binds 100-fold less
Major histocompatibility complex (MHC) class I and II strongly to H-2Db than the unsubstituted or wild-type
molecules have evolved to present antigenic peptides peptide (Haurum et al., 1995). Several K3G- and K2G-
at the cell surface, where they can be recognized by specific CTL clones were isolated and shown to require
the glycan for recognition. We found that all the H-2Db-
restricted K2G-specific clones exhibited a strong cross-7 To whom correspondence should be addressed (e-mail: tim.elliott@
reactivity toward K3G. In fact, in peptide titration experi-ndm.ox.ac.uk).
8 Both authors contributed equally to this work. ments, the K2G-specific clones tended to recognize
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Figure 1. Peptide Structures
The peptides used in this study are based on an H-2Db restricted
CTL epitope (WT) from Sendai Virus nucleoprotein residues 324±332.
K3G and K2G carry the Ser-O-GlcNAc substitution at positions 4
and 5 on the peptide backbone, respectively. The anchor residues
for peptide binding to H-2Db are underlined.
K3G at concentrations three orders of magnitude lower
than the concentration of K2G required to elicit the same
response. In addition, K3G-specific clones recognized
K2G very poorly or not at all. Despite these differences
in cross-reactivity, the T cell receptors (TCR) selected
by K2G- and K3G-specific CTL were remarkably similar
and in one case, the highly cross-reactive anti-K2G TCR
differed from a highly specfic anti-K3G TCR by only five
amino acids, including a two amino acid reduction in
length, in the junctional region of the b chain (Haurum
et al., 1995). Figure 2. Crystal Structure of the WT Peptide FAPGNYPAL Com-
In order to investigate the recognition of MHC class plexed with H2Db
I-glycopeptide complexes by CD81 cytotoxic T lympho- (A) The structure of WT (green) is shown superposed with the pre-
cytes (CTL) in more detail, we have determined the X-ray viously reported structure of the peptide ASNENMETM (blue) com-
plexed with H-2Db. (B) The structure of WT when complexed withcrystal structures of the WT peptide and the two
H2-Db (green) is shown superposed with the previously reportedN-acetylglucosamine-bearing glycopeptides complexed
structure of WT when complexed with H-2Kb (Fremont et al., 1992)with the murine class I allele H-2Db. Using existing MHC
(red). Components of this figure and Figures 3, 4, 5, and 7 wereclass I/TCR crystal structures as a basis, we have also
drawn using programs BOBSCRIPT (Esnouf, 1997) and Raster3D
modeled the glycopeptide-specific TCR clones raised (Merritt and Murphy, 1994) and structural superpositions were per-
against both K2G and K3G onto our MHC-glycopeptide formed using the program SHP (Stuart et al., 1979).
complexes. Here, we relate the striking differences in
the specificity of the clones to the structures of their
average root-mean-square (r.m.s) difference in Ca posi-
TCRs and the immunizing ligands and suggest a molec-
tions of 0.56 A. The greatest difference between these
ular basis for CTL cross-reactivity to glycopeptide an-
complexes and those of other MHC class I molecules
tigens.
is found in their quarternary structure, especially in the
pairing between the b2m and a3 domains, which will
be described elsewhere. In the following sections, theResults and Discussion
analysis of the structures will therefore be confined to
the peptide-binding groove.The peptides used in this investigation (Figure 1) are
synthetic glycopeptide analogs of the immunodominant
CTL epitope FAPGNYPAL from Sendai virus nucleopro- Crystal Structure of the Wild-Type
H-2Db/FAPGNYPAL Complextein residues 324±332 (Rotzschke et al., 1991). The gly-
copeptide analogs K3G and K2G carry the O-GlcNAc Figure 2A compares the conformation of the current
FAPGNYPAL peptide with that of the only other H-2Dbresidue attached to a serine substitution at P4 and P5,
respectively. Recombinant, soluble H-2Db class I mole- peptide complex reported to date (between H-2Db and
the influenza virus nucleoprotein peptide ASNENMETMcule (comprising heavy chain residues 1±284 followed
by six histidine residues bound to humanb2m [Springer [Young et al., 1994]). The side-chains of peptide residues
P2, P3, P5, and P9 are buried in the binding groove inet al., 1998]), was crystallized in complex with the wild-
type (WT) peptide, K3G, K2G, and the unglycosylated both complexes, and the main-chain conformation of
the two peptides is essentially identical (r.m.s. deviationpeptide FAPGSYPAL (K2), allowing the corresponding
series of three-dimensional structures to be determined for the nine Ca positions is 0.35 AÊ ). This degree of con-
served conformation between bound peptides is mark-by molecular replacement and refined at a resolution of
2.85 AÊ or better (see Experimental Procedures). The edly greater than that generally observed within sets
of nonamer peptides bound to common MHC class Ioverall structures of the different H-2Db-peptide com-
plexes reported in this work are very similar to those of molecules (Fremont et al., 1992; Garboczi et al., 1994;
Smith et al., 1996). The dominant role of asparagine atother MHC class I molecules, both mouse and human
(Madden, 1998). For example, the superposition of the P5 in the H-2Db anchor motif and the steric restrictions
placed on P6 and P7 side-chain orientation by a distinc-a1/a2 domains onto those of H-2Db complexed with an
Influenza virus peptide (Young et al., 1994) gives an tive hydrophobic ridge within the H-2Db binding groove
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(Young et al., 1994) may place unusually tight limits on coupling of O-GlcNAc and tyrosine side-chain confor-
mations. Stacking of the GlcNAc pyranose against aro-the conformation of nonamer peptides with the H-2Db
binding motif when bound in the groove. matic residues is a common feature of the carbohydrate
binding sites of both lysozyme and wheatgerm aggluti-The Sendai virus nucleoprotein-derived peptide FAP-
GNYPAL is an immunodominant H-2Kb-restricted CTL nin (Quiocho, 1998). Here, this interaction appears to
limit the O-GlcNAc conformation to an equilibrium be-epitope (Kast et al., 1991), as well as having the appro-
priate anchor residues for binding to H-2Db. The peptide tween two orientations. In both conformations, the gly-
can is solvent exposed and available for direct recogni-conformation in the current H-2Db/FAPGNYPAL com-
plex and in the previously reported H-2Kb/FAPGNYPAL tion by TCRs of glycopeptide-specific CTL, particularly
via the hydoxyl groups of the hexose ring.complex (Fremont et al., 1992) is, however, very different
for residues P4-P7 as a result of the different shapes of
the peptide binding groove of these two MHC class 1
Crystal Structure of H-2Db Complexed with K2Galleles and their different anchor motif specificities
In contrast to the structure with K3G, the complex with(r.m.s. on equivalent Ca positions is 1.9 AÊ , Figure 2B).
the second glycopeptide, K2G, differs profoundly fromThis provides a particularly clear demonstration of the
the WT and K3G structures (r.m.s. deviation of 1.4 AÊ ,influence of the MHC class I binding groove in determin-
Figure 4). The bulky O-GlcNAc ring is too large to being the conformation of the bound peptide.
accommodated in the peptide binding groove in theAs expected from the H-2Db anchor motif and previ-
same way as the asparagine anchor residue usuallyous peptide-binding and X-ray crystallographic studies
found at this position, and as a result the peptide back-(Haurum et al., 1994; Young et al., 1994), the H-2Db/
bone has been forced to undergo a major local re-FAPGNYPAL structure shows that the glycopeptide an-
arrangement, involving rotation of the peptide backbonealogs K3G and K2G represent substitutions at peptide
encompassing residues P4-P7 by 1808, compared withresidue side-chains that are respectively solvent ex-
WT (Figure 4C). This results in the orientation of theposed and buried in the WT complex.
glycan on K2G away from the peptide binding groove
rendering it exposed to solvent. In addition, the central
portion of the peptide is positioned further above theCrystal Structure of H-2Db Complexed with K3G
The crystal structure of the H-2Db/FAPS(O-GlcNAc)NYPAL binding groove with the Ca positions of residues P4 and
P5, respectively, some 0.7 and 3.6 AÊ higher than in WT.(K3G) complex, in which the O-GlcNAc is attached to
peptide position P4, shows clearly that the sugar residue The peptide backbone of K2G is more mobile than K3G,
and this mobility is particularly evident around P4 to P6is solvent exposed and projects above the level of the
a1 and a2 helices (Figures 3A and 3B). There is no as deduced from crystallographic B factors (see Experi-
mental Procedures).significant change in the conformation of the K3G pep-
tide backbone within the H-2Db binding groove com- Of the peptide side-chains common to the exposed
surfaces of the WT, K3G, and K2G complexes, the con-pared to that of the WT peptide (r.m.s. on equivalent Ca
positions is 0.35 AÊ ). In addition, the orientation of the formation of the tyrosine side-chain at P6 is very differ-
ent in K2G (see also Figure 4C). The aromatic ring ofpeptide side-chains is unaltered except at the P6 tyro-
sine, which reorientates slightly in order to stack against the P6 tyrosine reorientates downward to stack parallel
with that of MHC residue Tyr156 at the side of the peptidethe GlcNAc pyranose ring (Figure 3C). The reported
glycan specificity of CTL generated to this structure binding groove. This rearrangement allows the sugar to
project out of the binding groove. The sugar in the K2G(Haurum et al., 1995) is therefore likely to be due to direct
recognition of the sugar and not due to the recognition of complex makes no favorable interactions with H-2Db
comparable to the ring-stacking interaction present ina glycosylation-induced conformational change in the
bound peptide, as has been suggested previously for K3G; however, it again adopts a small number of differ-
ent conformations. Electron density (calculated in thesome class II MHC restricted glycopeptide-specific T
cells (Harding et al., 1993). Indeed, over 48% of the absence of any sugar coordinates) delineates a crown-
shaped arc indicative of at least three major sugar con-exposed peptide surface area is accounted for by the
glycan, which could therefore make a major contribution formations (Figures 4A and 4B).
An asparagine at P5 is a clear feature of the H-2Dbto the contact surface between the T cell receptor and
the MHC:glycopeptide complex. peptide binding motif and corresponds to the formation
of hydrogen bonds between the polar groups of the P5The X-ray crystallographic analysis bias free electron
density (calculated in the absence of any model for the asparagine side-chain and those of the MHC residue
glutamine 97 (Gln97) side-chain. For K2G, in the absencesugar) indicates the occurrence of two major conforma-
tions for the O-GlcNAc residue, each at similar occu- of a P5 asparagine anchor, alternative polar groups are
required to satisfy the hydrogen bonding potential ofpancy. Only one of these conformations is shown here
(see Figure 3); the second is rotated approximately 1808 Gln97. One possible source of such groups is the sugar
(Haurum et al., 1995); however, the current analysisaround the O-glycosidic bond. The sugar ring is orien-
tated in a similar plane for both conformations and there clearly demonstrates that in this case, two water mole-
cules fulfil this role (Figure 4D). As a result, the structureis some packing against the aromatic side-chain of the
tyrosine at peptide residue P6, which in turn stacks of the H-2Db binding groove in the K2G complex is es-
sentially unperturbed from that of the WT complex. Theagainst histidine 155 on the MHC a2 helix (Figure 3D).
Indeed, the electron density of the P6 side-chain is crystal structure for the H-2Db/FAPGSYPAL (K2) com-
plex (data not shown) indicates that a P5 serine residuesomewhat distorted in a manner consistent with some
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Figure 3. Crystal Stucture of H-2Db Complexed with the Glycopeptide K3G
(A) The mainchain of H-2Db is shown schematically in pale green and the peptide is depicted in ball-and-stick representation with the glycan
highlighted in yellow. Bias free 2FO-Fc electron density (calculated after rigid body refinement prior to the inclusion of any model for the
glycan, see Experimental Procedures) is shown as shaded chicken wire. The view is into the side of the peptide-binding groove through the
a2 helix.
(B) Same as in (A) but viewed down onto the binding groove.
(C) The structure of the K3G peptide when complexed with H-2Db (blue) is shown superposed with the WT structure (green). In the WT complex,
histidine 155 stacks against tyrosine 156 and donates a hydrogen bond to the carbonyl of glycine at P4, as in the H-2Db-Influenza virus
complex (Young et al., 1994), while tyrosine at P6 stacks against histidine 155. In K3G, tyrosine at P6 is oriented with its side-chain aromatic
ring perpendicular to that of tyrosine 156, while the histidine 155 side chain has flipped pointing away from the binding groove, parallel to
tyrosine at P6. The hydrogen bond between the histidine 155 side chain and the peptide is lost. Tyrosine at P6 has probably reoriented in
order to stack against the GlcNAc ring.
(D) The stacking of the K3G glycan, P6 tyrosine, and histidine 155 rings. The view is through the a1 helix (i.e., rotated through the O-glycosidic
bond by some 1808 relative to that of 3A).
can also mediate one of the standard hydrogen bonds it is more extensive than that seen for amino acid side-
chains of MHC-bound peptides in previously describedsuch that the unglycosylated form of the peptide (FAPG-
crystal structures.SYPAL) binds H-2Db with essentially the same confor-
We have used proton nuclear magnetic resonancemation as the optimal, tight-binding peptide of the WT
relaxation rate studies (CPMG) to investigate the mobili-complex (data not shown) albeit with much lower affinity
ties of carbohydrates in relation to the protein to which(Haurum et al., 1995).
they are attached (Wormald et al., 1997). CPMG experi-
ments on both K2G and K3G complexes indicated that
Mobility of the Attached Glycan the saccharide residues have similar dynamic properties
The X-ray crystallographic analyses of the K3G and K2G to the majority of the protein amino acid side-chains,
complexes established that the attached O-GlcNAc is since peaks corresponding to the glycans were not de-
solvent exposed in both glycopeptide complexes and tected in the CPMG experiments (data not shown). This
occupies an overlapping region of space, despite being technique is sensitive to oscillations over 3 AÊ that occur
positioned on two neighboring residues in the peptide significantly faster than the rate of protein tumbling in
(Figures 3 and 4). In both complexes, the glycan enjoys solutionÐin practice on a timescale of 1026 to 1028 sec.
some degree of conformational freedom, with electron Since the electron densities for K2G and K3G show a
density indicative of a small set of distinct conforma- range of conformations that are separated by greater
than 3 AÊ , it is reasonable to conclude that the attachedtions. Although this conformational variability is limited,
Structures of MHC Class I-Glycopeptide Complexes
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Figure 4. Crystal Stucture of H-2Db Complexed with the Glycopeptide K2G
(A) The mainchain of H-2Db is shown schematically in pale green, the peptide is depicted in ball-and-stick representation with the glycan
highlighted in yellow. Bias free 2FO-Fc electron density (calculated after rigid body refinement prior to the inclusion of any model for the
glycan, see Experimental Procedures) is shown as shaded chicken wire. The view is into the side of the peptide-binding groove through the
a2 helix.
(B) As for (A) but viewed down onto the binding groove.
(C) The structure of the K2G peptide when complexed with H-2Db (red) is shown superposed with the WT structure (green).
(D) The C pocket. The mainchain of H-2Db, which is essentially unchanged in conformation between the WT and K2G complexes, is depicted
schematically in pale green with selected MHC residue side-chain positions (also essentially unchanged between complexes). The WT peptide
structure with P5 Asn anchor residue is shown as a stick representation in gray. The K2G complex structure is shown superposed as a stick
representation in yellow. Hydrogen bonds in the WT complex are depicted as broken lines. The view is into the side of the peptide-binding
groove through the a2 helix.
sugars do not oscillate between their various conforma- clones are glycopeptide-specific, i.e., they do not recog-
nize the unglycosylated peptides K3 (FAPSNYPAL), K2tions on this timescale.
(FAPGSYPAL), or the WT peptide. Despite the similarity
between the TCR sequences, the clones have markedlyTCR Recognition: Implications of the K3G and K2G
Structures for T Cell Cross-Reactivity different patterns of cross-reactivity. K2G.6.9, although
raised against H-2Db/K2G, is highly cross-reactive, effi-We have previously shown that a number of CTL clones
generated to the glycopeptides K2G and K3G select ciently killing targets pulsed with K3G. In contrast,
K3G.5.8, raised against H-2Db/K3G, is highly specific,surprisingly similar TCR sequences (Haurum et al.,
1995). For example, CTL clones K2G.6.9 and K3G.5.8, recognizing only that peptide (Haurum et al., 1995).
These data can now be usefully reassessed in the con-raised against the K2G and K3G complexes, respec-
tively, express TCRa chains that are identical at the text of the H-2Db/K2G and H-2Db/K3G crystal structures.
The crystal structure for an MHC class I/TCR complexamino acid level (although they differ by one nucleo-
tide in the junctional region). They also share a common (Garboczi et al., 1996) provided the basis for a simple
modeling exercise to relate the TCR sequence data toTCR Vb and Jb segment usage. They therefore differ
only in the junctional region encoding the third comple- the characteristics of the TCR recognition surfaces pre-
sented by the K2G and K3G complexes.mentarity-determining region (CDR3) loop of the b chain
for which K2G.6.9 has the sequence LGANERLF and The preliminary, low resolution complex of a murine
TCR with H-2Kb (Garcia et al., 1996) and the refined HLAK3G.5.8 has the sequence FPGQSNERLF. All these TCR
Immunity
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A2/TCR complex of Garboczi and coworkers (Garboczi a subunit and the bCDR1 and 2 loops, common to both
clones, are with the regions of the MHC recognitionet al., 1996) revealed a common orientation of the TCR
relative to the MHC class I/peptide complex. Subse- surface that are essentially identical between K2G and
K3G. Although it is difficult to assess the direct interac-quent, refined, crystal structures for MHC class I/TCR
complexes (Ding et al., 1998; Garcia et al., 1998) have tion of TCR and glycan from the simple modeling, the
glycan interactions may be similar for the two receptors.further reinforced the concept of a basic standard geom-
etry for the interaction and in particular highlight the Possible TCR contact residues on the a chain, which
are shared by both CTL clones (tyrosine 31, Y31, andconservation of the TCR a chain docking geometry. For
the K2G and K3G complexes, this implies that the CDR tyrosine 100, Y100), are shown in Figures 5B, 5C, 5E, and
5F. The potential TCR contact residues on the bCDR33 loops of the TCR a and b chains will be positioned
over the central portion of the peptide as shown in Figure loop are also shown. Although the sequence of this loop
differs between the two clones, they have both selected5. Several important points are immediately apparent
from this juxtaposition of MHC class I complex and TCR. asparagine at position 103 (N103) and glutamate at posi-
tion 104 (E104). These have polar side-chains suitableThe model shows that the glycan of both K3G (Figures
5A±5C) and K2G (Figures 5D±5F) is accommodated in for hydrogen bonding with the sugar hydroxyls. It is
therefore likely that a common glycan binding pocketa central cavity formed between the two CDR3 loops at
the interface between the TCR a and b chains. Second- with similar TCR-sugar contacts allows the CTL raised
to K2G to cross-react with K3G.ly, the size of this cavity may impose some restrictions
on the number of conformations that the glycan could In contrast, the clone raised against K3G (K3G5.8)
does not reciprocally recognize K2G. As well as theadopt when it is part of a complex with the glycan-
specific TCR. For the K3G complex sugar, one con- increased volume of space occupied by the K2G glycan
compared to that of K3G, the P4-P5 portion of K2G isformation can certainly be accommodated within the
standard complex interface as shown in Figure 5A, but more prominent, lying some 3.6 AÊ further above the
binding groove than for K3G, raising the position of thethe second (data not shown) may be disfavored since
this sugar position would occlude the standard TCR a glycan slightly relative to the a1 and a2 helices of H-2Db
(see Figure 4). In addition, the glycan group in K2G lieschain positioning by interfering with the aCDR2.
Similarly, not all of the arc-shaped space encom- further toward the C terminus of the peptide and is
orientated such that it extends off the medial line of thepassing the different sugar conformations in the K2G
complex can be accommodated by a standard TCR peptide-binding groove and substantially closer to the
a1 helix of the H-2Db molecule. The lateral positioninginterface. However, the shorter bCDR3 loop of the K2G-
specific TCR, which contains small amino acid side- and greater number of conformations of the K2G glycan,
along with the increased mobility of the peptide back-chains at positions 101 and 102 (Gly and Ala compared
to Gln and Ser in the bCDR3 of the K3G-specific TCR) bone supporting it, may make it less easily accommo-
dated between the aCDR3 and bCDR3 loops of K3G5.8is likely to generate a larger pocket between the aCDR3
and bCDR3 loops. This selection of a shorter bCDR3 than the K3G glycan. As discussed earlier, this is likely
to impact on the ability of the TCR b chain to contributeloop may be essential to mitigate enthalpic penalties if
the TCR is to accommodate one or more of the arc of fully to the interface with K2G. This simple observation
accords well with the observed difference in the lengthconformations adopted by the glycan in K2G. Indeed,
it is possible that since the glycan of K2G may oscillate of the bCDR3 loop: the only difference between the
TCR of CTL clones raised against K2G and K3G. Thebetween conformations on a timescale comparable to
the lifetime of the TCR:MHC complex (i.e., longer than failure of K3G.5.8 to cross-react with K2G is most likely
to be a direct result of its longer bCDR3 loop, which1026 sec), a shorter CDR3 loop may be selected by K2G
in order to allow the glycan to remain mobile when the would be less likely to accommodate the prominent P4-
P5 and glycan of this peptide. A similar situation hasTCR is bound. This would also have the effect of reduc-
ing the entropic penalty upon TCR binding. This latter been described recently (Ding et al., 1998) for two TCR
surfaces that contact the same MHC/peptide complexpossibility is notable in light of recent evidence from a
kinetic and thermodynamic analysis that the affinity of in which differences in reactivity could be attributed to
the different-sized pockets between the TCR a and bT cell receptor binding to its class I MHC:peptide ligand
is dominated by unfavorable entropic effects (Willcox subunits that in that system accommodate the peptide
et al., unpublished data). It is important to note, however, ligand P5 side-chain.
that a significant amount of tilt, rotation, and transloca-
tion is seen on comparison of the binding orientation of
TCR Recognition: Implications of the K3G and K2GTCRs in different MHC class I/TCR complexes (Ding et
Structures for T Cell Promiscuityal., 1998; Garcia et al., 1998; Teng et al., 1998), indicating
In order to investigate the contribution of interactionsthat there is some variability of docking orientations
between the peptide amino acid side-chains and TCRswithin the standard TCR positioning that may not be
expressed by both specific and cross-reactive CTL,represented by the models shown in Figure 5.
we tested the ability of H-2Db-restricted CTL clonesThese models suggest a molecular basis for the cross-
K3G.6.15 and K2G.6.9 to recognize K3G analogs car-reactivity of CTL clones raised to K2G. In these models,
rying alanine substitutions in the C-terminal half of thethe glycans of both K2G and K3G are accommodated
peptide that would be expected to make contact within a similar manner by their respective TCRÐthat is, in
the bCDR3 loop. As was the case for clone K3G5.8 (seea central glycan binding pocket formed between the
CDR3 loops. Many of the major interactions of the TCR above), clone K3G.6.15 does not cross-react with K2G
Structures of MHC Class I-Glycopeptide Complexes
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Figure 5. Molecular Models Showing the K3G and K2G Structures in the Context of the Standard Docking of MHC Class I and TCR
(A) A model for the TCR of glycopeptide-specific CTL clone K3G.5.8 is shown positioned over the K3G structure (by comparison with published
TCR-MHC co-crystal complexes, see Experimental Procedures). The main-chain is shown schematically for the TCR a chain (green), TCR b
chain (blue) and H-2Db (pale green). The peptide is depicted in ball-and-stick representation with the glycan highlighted in yellow. The electron
density of Figure 3 is also overlaid onto the figure to emphasize the full range of sugar conformations observed experimentally in the unliganded
MHC class I crystal structure. The view is into the side of the peptide-binding groove through the a2 helix and is shown in close up in (B)
with the a2 helix of H-2Db removed for clarity. (C) Same as in (B) but viewed down onto the binding groove. (D±F) A model for the TCR of
glycopeptide-specific CTL clone K2G.6.9 is shown positioned over the K2G structure. The view in (D), (E), and (F) is as in (A), (B), and (C),
respectively.
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Figure 6. Anti-K2G CTL Are More Promiscu-
ous than Anti-K3G CTL
Peptide specificity of CTL clones K2G.6.9
(raised against K2G) and K3G.6.15 (raised
against K3G) tested against 51Cr-labeled tar-
get cells T2-Db in the presence of K3G (upside
down triangle), K2G (closed circle), K3G with
a tyrosine to alanine substitution at position 6
(closed square), K3G with a proline to alanine
substitution at position 7 (open diamond),
and K3G with a lysine to alanine substitution
at position 9 (closed triangle).
(Figure 6) and is therefore representative of the K3G- formed by residues of both the TCR a and b chain. The
second is that it disfavors contact between the CDR3specific CTL clones, while K2G.6.9 is reactive to both
K2G and K3G complexes (Figure 6). loop of the TCR b chain and the peptide part of the
glycopeptide ligand. The shorter bCDR3 loop may alsoFigure 6 also shows that K2G.6.9, but not K3G.6.15,
could tolerate alanine substitutions at peptide positions have been selected to allow the region of the bound
K2G peptide around P6 and P7 (which lie directly below6 and 7. Thus, the two CTL clones differ markedly in
their sensitivity to the variant peptide ligands bearing this loop in our models), as well as the glycan, to remain
mobile, thus minimizing the loss of entropy upon TCRchanges at the exposed P6 and P7 side-chains but not
at the buried P9 anchor. Once again, K2G.6.9 displays binding. Taken together, these lead to the selection of
a highly promiscuous TCR that displays a high degreea broader spectrum of reactivity than CTL clones raised
against K3G.
The CTL clones K2G.6.9 and K3G.6.15 express the
same TCR Vb segment that encodes the bCDR1 and 2
loops but differ in the junctional region corresponding
to the bCDR3 loop (the sequence for K3G.6.15 is
LELSQNTLY [Haurum et al., 1995]). The bCDR3 loop
of clone K3G.6.15 was modeled in the same way as
described above, using the crystal structure of the HLA
A2/TCR complex (Garboczi et al., 1996) as a template.
Figure 7 shows that, as above, the CDR3 loop of
K3G.6.15 (blue), like that of K3G.5.8, is extended relative
to that in K2G.6.9 (red), by virtue of being one residue
longer and having a serine at position 102 rather than
alanine and leucine at position 101 rather than glycine.
K3G.6.15 may therefore have considerable contact with
the peptide at P6 and P7, mediated perhaps by hydro-
gen bonding through serine 102 and/or van der Waals
contacts through leucine 101 of the TCR. The shorter
loop of K2G.6.9 would be less likely to make this contact.
This local difference in TCR structure is fully consistent
with the difference in the ability of the CTL to tolerate
alanine substitutions at P6 and P7 in the recognition
surface presented by the K3G complex. Interestingly, Figure 7. Molecular Models of K3G- and K2G-Specific TCR Recog-
both K3G.6.15 and K2G.6.9 were sensitive to an alanine nizing the H-2Db/K3G Complex
substitution at P1 (data not shown) that is solvent ex- The TCR models were positioned by comparison with published
TCR-MHC co-crystal complexes (see Experimental Procedures).posed and would be expected to make contacts with
The mainchain is depicted schematically for the K2G.6.9 a chainthe TCRa chain.
(green), K2G.6.9 b chain (red), and K3G.6.15 b chain (blue). PotentialThere are therefore two consequences of selecting a
TCR-sugar contact residues are marked as spheres at C a positions.short bCDR3 loop in response to antigenic challenge
With the exception of the TCR b position 101 and 102 amino acid,
by K2G presented by H-2Db. The first is that it allows side-chains have been omitted. Residues at peptide positions P6
access of the K2G glycanÐwhich occupies a large vol- and P7 are highlighted in pale blue. The view is into the side of the
peptide-binding groove through the a 2 helix.ume of spaceÐto a central binding pocket, which is
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of cross-reactivity toward variant peptides, e.g., K3G (in cavity required to accommodate the K2G glycan also
encompassing the space occupied by one of the K3Gwhich the glycan occupies a smaller but overlapping
volume of space) and K3G alanine substitutes. sugar conformations and (2) some common TCR-sugar
contacts. Some of these contacts, for example with his-
tidine 29 and asparagine 30 of the bCDR1, could explain
Perspectives the striking preference for Vb11 segment-usage by CTL
The recognition of O-GlcNAc modified peptides by T cells raised to O-GlcNAc modified peptides; and tyrosine
could be highly significant as glycosylation could create 31 on the aCDR1 for the preferential use of Va5.3.18
a T cell neoepitope without requiring a change at the (Haurum et al., 1995). Interestingly, several motifs that
genetic level. Alterations in intracellular metabolism that were found among the bCDR3 loops of O-GlcNAc-spe-
lead to changes in posttranslational modifications in- cific CTL (ªNERLFº, ªSYEQ,º and ªSAETLYº [Haurum et
cluding cytosolic glycosylation are known to occur in al., 1995]) have also recently been observed among MHC
development, autoimmunity, and malignancy. O-GlcNAc class II restricted T cells recognizing glycopeptides with
is known to be dynamically regulated and levels change hydroxylysine-linked Galactose modifications (Corthay
in response to cellular activation (Hart et al., 1996). Also, et al., 1998). The specificity of CTL clones K3G.5.8 and
many pathogen antigens including viral, trypanosomal, K3G.6.15 seems to be determined in part by their longer
schistosomal, leishmanial, and malarial proteins are bCDR3 loop that may limit the size of the ªglycan binding
O-GlcNAc modified (Hart et al., 1989). pocketº in such a way as to restrict the access of
We have shown that the O-GlcNAc group of two O-GlcNAc of K2G, which occupies several conforma-
H-2Db-associated glycopeptides is solvent exposed and tions within a larger volume of space and in a slightly
therefore available for direct recognition by TCR, sup- different position. The long bCDR3 loop of K3G.6.15
porting the conclusion that glycopeptide-specific CTL also results in greater selectivity at p6 and p7, which
recognize the glycan directly. This idea is further sup- probably make contacts with this loop.
ported by our models of glycopeptide-specific TCR that A high degree of cross-reactivity may be an intrinsic
appear to have conserved amino acid side-chains that and necessary feature of T cell reactivity (Mason, 1998).
are of an appropriate location and chemical nature to It is the underlying feature of several important immuno-
interact with serine modified with O-GlcNAc. These logical phenomena such as positive selection in the thy-
models also indicate that the sugar ring is small enough mus (Bevan, 1997), alloreactivity (Brock et al., 1996), and
to allow TCR to contact peptide and MHC simultane- autoimmunity (Sinha et al., 1990), and yet the molecular
ously. basis for such cross-reactivity has so far remained rela-
In the case of K2G, where the substitution is on a tively unexplored. Molecular mimicry is thought to be
peptide-anchor position, the sugar profoundly affects an important mechanism in experimental autoimmune
the conformation of the bound peptide in the H2-Db diseases such as adjuvant arthritis in rats (van Eden et
groove. Thus, the region of the peptide immediately al., 1988), Arthritides (Fielder et al., 1995), and in inflama-
surrounding the Ser-O-GlcNAc is rotated through 1808 tory CNS disease (Wucherpfenning and Strominger,
in such a way as to expose the glycan to solvent. This 1995; Steinman, 1996). Our results provide a picture of
leaves a specificity-determining pocket in the H2-Db how molecular mimicry by two related ligands can be
peptide-binding groove empty and H-bonds that are interpreted at the T cell level. This particular model is
normally formed with the N anchor side-chain are in- interesting because it illustrates two ways in which a
stead made with water molecules. highly cross-reactive (i.e., potentially autoreactive) CTL
The O-GlcNAc of K3G adopts two conformations, could be generated. The first conforms to the classic
which together occupy a relatively restricted volume of model of molecular mimicry in which a viral glycopeptide
space of around 260 AÊ 3, whereas the same sugar in K2G (e.g., K2G) elicits a highly cross-reactive T cell response
adopts at least three conformations that may occupy a that encompasses recognition of a self-peptide (e.g.,
volume of space of up to double that in K3G. It is unlikely K3G or any of the alanine substitutions). In the second,
that the glycan exchanges between these conforma- a neoepitope could be generated following the aberrant
tions rapidly (1 3 1026 to 1 3 1028 sec) but may neverthe- glycosylation of a self peptide (e.g., glycosylation of
less still exchange on a timescale that is comparable K2 to give K2G), leading to an anti-self (e.g., anti-K3G)
with the lifetime of the TCR:MHC complex. This degree reactivity.
of conformational variation has so far not been seen for
amino acid side-chains of peptides bound to MHC class Experimental Procedures
I molecules, and whether it is a general property of
Peptide Synthesiscarbohydrate-modified side-chains remains to be seen.
Peptides and glycopeptides were synthesized as described inFor these structures, the flexibility of the glycan side-
Haurum et al. (1994).
chains seem to contribute to the pattern of cross-reac-
tivity we have observed between CTL raised to the two Protein Expression, Purification, and Crystallization
Purified, peptide receptive H-2Db-human b2m (hb2m) heterodimersglycopeptides.
were produced in CHO K1 cells exactly as described in Springer etWe have exploited the small differences in the se-
al. (1998). To remove residual contaminating proteins/peptides fromquence of three glycopeptide-specific TCRs with strik-
the protein preparation, the purified H-2Db was denatured and re-ingly different patterns of recognition in order to interpret
folded as described in Elliott and Eisen (1990), with the following
T cell cross-reactivity at the molecular level. In summary, modifications. Complexes were diluted 1 in 10 in 6 M Guanidine HCl
the highly cross-reactive CTL clone K2G.6.9 recognized in PBS and dialysed overnight at 48C. The denatured protein was
then concentrated and the heavy and light chains separated by gelboth glycopeptides by virtue of (1) the necessarily large
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Table 1. Crystallographic Data Collection and Refinement Statistics
Data Collection Statistics
Peptide Unit Cells (AÊ ) Resolution (AÊ ) Rmerge (%) Completeness (%)
WT 60.8, 58.1, 74.7 2.85 (2.92±2.85) 9.6 (37.6) 96.1 (86.2)
FAPGNYPAL b 5 108.3
K2 60.8, 58.6, 75.3 2.80 (2.88±2.80) 9.5 (42.5) 99.5 (98.4)
FAPGSYPAL b 5 108.5
K2G 61.4, 58.4, 77.3 2.60 (2.66±2.60) 5.3 (15.9) 90.2 (61.2)
FAPGS(O-GlcNAc)YPAL b 5 108.9
K3G 61.1, 58.3, 77.2 2.65 (2.73±2.65) 6.0 (17.6) 97.0 (95.1)
FAPS(0-GlcNAc)NYPAL b 5 108.6
Refinement Statistics
WT K2 K2G K3G
Resolution limits (AÊ ) 10.0-2.85 10.0-2.80 10.0-2.60 10-2.65
n. reflections 11060 11701 14564 14363
n. reflections Rfree set 1145 1184 1482 1451
Rfree 28.5 27.3 28.5 26.3
Rfactor 21.4 21.0 22.7 19.4
n. solvent molecules 26 40 63 105
Rmsd bonds 0.007 0.007 0.008 0.006
Rmsd angles 1.28 1.27 1.34 1.25
Rmsd dihedrals 25.44 25.41 25.67 25.54
Rmsd impropers 1.08 1.05 1.14 1.04
Rmsd for bond B 1.92 1.71 1.71 1.63
Rmsd for angle B 3.28 2.86 2.90 2.76
Average B
Heavy chain 60 56 57 55
b2-microglobulin 50 48 50 46
Peptide 60 69 76 56
filtration. The H-2Db and hb2m chains were then recombined in 8 M domain (residues 183±272), and the b2-m subunit. Unambiguous
solutions were found for the three independent probes that whenurea and then dialysed against TBS. After further purification by
gel filtration, fractions containing the highest amount of B22.249 combined resulted in a correlation coefficient of 0.62 and an R-factor
of 0.43, for data between 10.0 and 3.0 AÊ resolution. The three do-(Hammerling et al., 1979)-reactive material were pooled and mixed
with a 10-fold excess of peptide. mains were then rigid-body fitted into the unit cells of the various
peptide complexes using X-PLOR (Brunger, 1992). Electron density
maps calculated at this stage with coefficients 2Fo-Fc and Fo-FcX-Ray Data Collection, Phasing, and Refinement
Crystals were grown by vapor diffusion at 48C using microbridges showed clear and continuous density in the binding cleft for nine
amino acid residues in the WT, K2, and K3G complexes. For the(Harlos, 1992) from sitting drops containing 1 ml of protein solution
(typically 10 mg/ml H-2Db peptide complex in Tris Buffered Saline K2G complex, however, weak density was observed between resi-
dues P4 to P5, which became better defined at later stages in the[pH 7.5]) plus 1 ml of reservoir solution (15%±23% PEG 6000,
100 mM Ammonium Sulphate, and 100 mM MES [pH 5.0]). Crystals structure refinement. Automatic refinement of the four peptide com-
plexes, which included rigid body, overall anisotropic scaling, bulkwere harvested to a modified reservoir solution containing 25% PEG
6000, 100 mM ammonium sulphate,100 mM sodium chloride, and 50 solvent correction, positional and individual atomic temperature (B),
factor refinement, and, occasionally, simulated annealing, was car-mM MES [pH 5.0]. For cryo-crystallographic data collection, crystals
were transferred stepwise to harvest buffer supplemented with pro- ried out with standard protocols in program X-PLOR and was alter-
nated with manual rebuilding in the interactive graphics program Ogressively higher concentrations of glycerol up to a final concentra-
tion of 20%, flash-cooled in liquid propane, and stored at 21708C (Jones, 1985). After extending the resolution to the diffraction limits
of each complex, and further refinement until the agreement factorin liquid nitrogen. Diffraction data sets were collected at station 7.2
of the Daresbury Synchrotron Light Source, with a MarResearch appeared to have reached a minimum (R free between 0.31 to 0.34
and R factor between 0.23 to 0.25, depending on the structure),imaging plate detector, for the WT complex; station BM14 of the
European Synchrotron Radiation Facility, using a MarResearch im- models of the appropriate peptides were included in the refine-
ments. Since the carbohydrate moieties of the K2G and K3G pep-aging plate for the K3G complex and a CCD detector for the K2G
complex; and in house, using a MarResearch imaging plate mounted tides tended to refine to very high B factors and always showed
very weak density in the electron density maps, they were excludedon a Rigaku RU generator fitted with Yale mirror optics, for the K2
complex. The diffraction data were auto indexed, integrated, scaled, from the models. Density remained clear for the rest of the peptide
in the different complexes with the exception of TyrP5 side-chainand merged using programs DENZO and SCALEPACK (Otwinowski
and Minor, 1997). All crystals belong to the monoclinic space group in the K2 complex structure. For the WT, K2, and K3G complexes,
the electron density maps are consistent with a mixture of cis andP21 with similar unit cell dimensions. Crystallographic data collection
statistics are reported in Table 1. The structure of H-2Db/hb2-m trans conformations for the peptide bond N-terminal to the P5-
Pro. The mean B value for the protein atoms resulting from thecomplexed with a mixture of endogenous peptides (data not shown)
was solved by molecular replacement with the program AMoRe refinements (from 53 A2 to 57 A2) agree well with those obtained
from Wilson plots calculated for the different data sets (ranging from(Navaza, 1994). The models used were the H-2Db heavy chain from
the crystal structure of its complex with an influenza virus peptide 48 to 61 A2). For the WT and K3G complexes, the mean B values
for the peptide atoms are similar to those for the respective heavy(Young et al., 1994) (Protein Data Bank identification code 1hoc)
and the humanb2-microglobulin subunit of the HLA-A2 structure chains. For the low-affinity peptides, K2 and K2G, the mean B values
for their peptide atoms are significantly higher that the mean value(Protein Data Bank identification code 3hla). The rotation and trans-
lation searches were carried out independently for three different of the rest of the molecule, perhaps reflecting a partial occupancy.
The statistics of all four refined structures are presented in Table 1.probes: the H-2Db a1/b2 domain (residues 1±174), the H-2Db a3
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All have the characteristics of well-refined protein structural models, M. (1996). Immunization with glycosylated Kb-binding peptides gen-
erates carbohydrate-specific, unrestricted cytotoxic T cells. Eur. J.including good geometry, as defined by PROCHECK (Laskowski et
al., 1998), and low values for R free and R factor. Immunol. 26, 544±551.
Bevan, M.J. (1997). In thymic selection, peptide diversity gives and
Glycan Mobility Studies by Proton NMR takes away. Immunity 7, 175±178.
Samples for NMR were prepared by in vitro refolding of a soluble Brock, R., Weismuller, K., Jung, G., and Walden, P. (1996). Molecular
H2-Db molecule expressed in E. coli around either K2-OGlcNAc or basis for the recognition of two structurally different major histocom-
K3G peptide, as described in Rigney et al. (1998). The protein was patibility complex/peptide complexes by a single T cell receptor.
then exchanged into PBS/D20 using centriprep 10 (Amicon). All Proc. Natl. Acad. Sci. USA 93, 13108±13113.
spectra were recorded on a Varian Unity 500 spectrometer. Trans-
BruÈ nger, A.T. (1992). XPLOR version 3.1: a system for X-ray crystal-verse relaxation rates (T2) were measured using a CPMG (Meiboom
lography and NMR. Department of Molecular Biophysics and Bio-and Gill, 1958) sequence (908 - {t - 1808 - 2t -1808 - t}n - aqq) with
chemistry, Yale University, New Haven, CT.a 0.00025 sec delay between pulses (t) and the total delay from first
Corthay, A., Backlund, J., Broddefalk, J., Michaelsson, E., Goldsch-pulse t acquisition (4tn) varying from 0.001 to 0.256 sec). X scans
midt, T.J., Kihlberg, J., and Holmdahl, M. (1998). Epitope glycosyla-were required for adequate signal-to-noise ratios. Spectra were Fou-
tion plays a critical role for T cell recognition of type II collagen inrier-transformed directly with no prior mathematical manipulation.
collagen-induced arthritis. Eur. J. Immunol. 28, 2580±2590.The final signal-to-noise ratios obtained were sufficiently high to
enable observation of slowly relaxing aromatic side-chains (mainly Deck, B., Elofsson, M., Kihlberg, J., and Unanue, E.R. (1995). Speci-
histidines). ficity of glycopeptide-specific T cells. J. Immunol. 155, 1074±1078.
Ding, Y.-H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W., and
Establishment of CTL Clones and CTL Assays Wiley, D.C. (1998). Two human T cell receptors bind in a similar
Peptide- and glycopeptide-specific CTL clones are described in diagonal mode to the HLA-A2/Tax peptide complex using different
Haurum et al. (1994). The peptide transporter-deficient cell line T2 TCR amino acids. Immunity 8, 403±412.
transfected with H-2Db (a gift from P. Cresswell, Yale) was used as Dudler, T., Altmann, F., Carballido, J.M., and Blaser, K. (1995). Car-
target cells in conventional chromium release assays for measure- bohydrate-dependent, HLA class II-restricted, human T cell re-
ment of peptide-specific cytotoxicity mediated by the CTL clones. sponse to the bee venom allergen phospholipase A2 in allergic
In some assays, the target cells were prepulsed with an excess patients. Eur. J. Immunol. 25, 538±542.
of peptide (50 mM) and then labeled with 51Cr (Amersham) before
Elliott, T.J., and Eisen, H.N. (1990). Cytotoxic T lymphocytes recog-incubation with the CTL clones for 4 hr at 378C in 96-well plates. In
nize a reconstituted class I histocompatibility antigen (HLA-A2) asother assays, serial dilutions of peptide (final concentration 50, 5,
an allogeneic target molecule. Proc. Natl. Acad. Sci. USA 87, 5213±0.5, and 0.05 nM) were added directly to the CTL clones and 51Cr
5217.labeled target cells.
Esnouf, R.M. (1997). An extensively modified version of MolScript
that includes greatly enhanced colouring capabilities. J. Mol. Graph.Molecular Modeling
15, 133±138.The framework (V and J segment) sequences for TCR clones
K2G.6.9, K3G.5.8, and K3G.6.15 were substituted into the Va and Fielder, M., Pirt, S.J., Tarpey, I., Wilson, C., Cunningham, P., Ettelaie,
Vb domains of a murine TCR crystal structure (Garcia et al., 1996) C., Binder, A., Bansal, S., and Ebringer, A. (1995). Molecular mimicry
using MUTATE (Esnouf, 1997). Using program SHP (Stuart et al., and ankylosing spondylitis: possible role of a novel sequence in
1979), the TCR models for K2G.6.9, K3G.5.8, and K3G.6.15 were pullulanase of Klebsiella pneumoniae. FEBS Lett. 369, 243±248.
positioned onto the TCR in the HLA A2/TCR complex. The correct Fremont, D.H., Matsumura, M., Stura, E.A., Peterson, P.A., and Wil-
length CDR3 loops were manually rebuilt in program FRODO (Jones, son, I.A. (1992). Crystal structures of two viral peptides in complex
1985) using the available murine (Garcia et al., 1996) and human with murine MHC class I H-2Kb. Science 257, 919±927.
(Garboczi et al., 1996) TCR structures as guides. The crystal struc-
Garboczi, D.N., Madden, D.R., and Wiley, D.C. (1994). Five viral
ture of the HLA A2/TCR complex of Garboczi and coworkers (Gar-
peptide-HLA-A2 co-crystals. Simultaneous space group determina-
boczi et al., 1996) was then used as a template to orientate these
tion and X-ray data collection. J. Mol. Biol. 239, 581±587.
TCR models relative to the crystal structures of the H-2Db-K3G and
Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., andH-2Db-K2G complexes. The MHC class I structures were positioned
Wiley, D.C. (1996). Structure of the complex between human T-cellby superposition onto HLA A2 using program SHP (Stuart et al.,
receptor, viral peptide and HLA-A2. Nature 384, 134±141.1979) based on all structurally equivalent Ca atoms of the heavy
Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson,chain and hb2m. The resultant series of model complexes were
M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An alphabetainspected in the interactive graphics program O (Jones et al., 1991).
T cell receptor structure at 2.5 A and its orientation in the TCR-MHC
complex. Science 274, 209±219.Acknowledgments
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